Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma

Authors: Dutta, Rudra P. ¹, Thibaud, Santiago ², Leshchenko, Violetta ¹, Ram, Meghana ³, Melnekoff, David T. ⁴, Bhalla, Sherry ¹, Restrepo, Paula ⁴, Gupta, Vikas A. ⁵, Barwick, Benjamin G. ⁵, Newman, Scott ⁶, McCafferty, Jonathan ⁷, Hantash, Feras ⁸, Nooka, Ajay K. ⁵, Cho, Hearn J. ², Richard, Shambavi ², Rodriguez, Cesar ², Rossi, Adriana ², Sanchez, Larysa ², Chari, Ajai ², Boise, Lawrence H. ⁵, Jagannath, Sundar ², Richter, Joshua ², Parekh, Samir ^{1, 2}, Laganà, Alessandro ^{1, 3, 4, ∗}

Source: In Blood Neoplasia December 2024 1(4)

Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common

Authors: Newfield, Ron S., Jiang, Wen, Sugganth, Daniel X., Hantash, Feras M., Lee, Euyhyun, Newbury, Robert O.

Source: In International Journal of Pediatric Otorhinolaryngology June 2022 157

Method for detecting cystic fibrosis

Low Circulating 25-Hydroxyvitamin D Concentrations Are Associated with Defects in Insulin Action and Insulin Secretion in Persons with Prediabetes ,

Authors: Abbasi, Fahim ^*, Blasey, Christine, Feldman, David, Caulfield, Michael P, Hantash, Feras M, Reaven, Gerald M

Source: In The Journal of Nutrition April 2015 145(4):714-719

Gain of chr1q Portends Poor Outcomes in Multiple Myeloma Patients Treated with Venetoclax

Authors: Lagana, Alessandro, Thibaud, Santiago, Melnekoff, David T. ^*, Restrepo, Paula ^*, Leshchenko, Violetta ^*, McCafferty, Jonathan ^*, Newman, Scott ^*, Kern, Abbi ^*, Corrigan, David ^*, Hantash, Feras ^*, Rossi, Adriana, Rodriguez, Cesar, Sanchez, Larysa, Richard, Shambavi, Chari, Ajai, Cho, Hearn J., Jagannath, Sundar, Richter, Joshua, Parekh, Samir

Source: In Blood 15 November 2022 140 Supplement 1:4388-4390

Cystic fibrosis transmembrane conductance regulator gene mutations

Method to detect repeat sequence motifs in nucleic acid

FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: Insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States

Authors: Hantash, Feras M. ^*, Goos, Dana M., Crossley, Beryl, Anderson, Ben, Zhang, Ke, Sun, Weimin, Strom, Charles M.

Source: In Genetics in Medicine January 2011 13(1):39-45

61. Clinical whole exome/whole transcriptome analysis detects clinically relevant structural alterations in Multiple Myeloma

Authors: Calvo, Maria Nieves, Caruthers, Sean, Tripodi, Joseph, Houldsworth, Jane, Fink, Marc, Newman, Scott, Chen, Rong, Zhang, Wanying, Liu, Liu, Shi, Yong, Jun, Tomi, Onel, Ken, Oh, William, Edelmann, Lisa, Schadt, Eric, Rossi, Michael, Hantash, Feras, Al-Kateb, Hussam

Source: Cancer genetics. 268(S1):20-20

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100176328139.0x000001&indx=1&recIds=ETOCvdc_100176328139.0x000001

MP27-10 CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING FOR PROSTATE CANCER IN THE CONTEXT OF A CHANGING TREATMENT LANDSCAPE

Authors: Griffin, Jacqueline R., Jun, Tomi, Guin, Sunny, Chi-Hung Liaw, Bobby, Patel, Vaibhav G., Tsao, Che-Kai, Rossi, Michael R., Chen, Rong, Zhou, Xiang, Hantash, Feras, Oh, William K.

Source: Journal of urology. 207(5):e453-e453

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165586011.0x000001&indx=1&recIds=ETOCvdc_100165586011.0x000001

Clinical utility of next-generation sequencing for prostate cancer in the context of a changing treatment landscape.

Authors: Griffin, Jacqueline R., Jun, Tomi, Liaw, Bobby Chi-Hung, Guin, Sunny, Tsao, Che-Kai, Patel, Vaibhav G., Rossi, Michael, Zhou, Xiang, Hantash, Feras, Chen, Rong, Oh, William K.

Source: Journal of clinical oncology. 40(6 suppl):112-112

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152979019.0x000001&indx=1&recIds=ETOCvdc_100152979019.0x000001

Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: Implications for fragile X syndrome carrier and newborn screening

Authors: Hantash, Feras M. ^*, Goos, Dana G., Tsao, David, Quan, Franklin, Buller-Burckle, Arlene, Peng, Mei, Jarvis, Michael, Sun, Weimin, Strom, Charles M.

Source: In Genetics in Medicine March 2010 12(3):162-173

Apparent Homozygosity of a Novel Frame Shift Mutation in the CFTR Gene Because of a Large Deletion

Authors: Hantash, Feras M., Rebuyon, Arlene, Peng, Mei, Redman, Joy B., Sun, Weimin, Strom, Charles M.

Source: In The Journal of Molecular Diagnostics 2009 11(3):253-256

Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome

Authors: Strom, Charles M. ^*, Huang, Donghui, Li, Yuanyin, Hantash, Feras M., Rooke, Jenny, Potts, Steven J., Sun, Weimin

Source: In Genetics in Medicine April 2007 9(4):199-207

Characterization of a Recurrent Novel Large Duplication in the Cystic Fibrosis Transmembrane Conductance Regulator Gene

Authors: Hantash, Feras M. ^*, Redman, Joy B. ^*, Goos, Dana ^*, Kammesheidt, Anja, McGinniss, Matthew J. ^*, Sun, Weimin ^*, Strom, Charles M. ^*

Source: In The Journal of Molecular Diagnostics 2007 9(4):556-560

METHOD FOR DETECTING CYSTIC FIBROSIS

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE MUTATIONS

Cystic fibrosis transmembrane conductance regulator gene mutations

Methods of detecting TPMT mutations

Sample processing for nucleic acid amplification